Q3 2019 Allogene Therapeutics Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and thank you for standing by, and welcome to Allogene Therapeutics' Third Quarter 2019 Conference Call. (Operator Instructions) Please be advised today's conference will be recorded.
I would now like to turn the conference over to Christine Cassiano, Chief Communications Officer. Ms. Cassiano, you may go ahead.
Thank you, operator, and good morning. Before market opened today, Allogene issued 2 press releases. One press release discusses an exclusive collaboration with Notch Therapeutic to develop IPSE based AlloCAR therapy and the other provides a corporate update and financial results for the quarter ended September 30, 2019. The press release is available on our website at www.allogene.com. We remind listeners that today's call is being webcast on our website and will be available for replay. Joining me on the call today are Dr. David Chang, President and Chief Executive
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |